Screening for viral hepatitis in migrants in East London
ISRCTN | ISRCTN82598401 |
---|---|
DOI | https://doi.org/10.1186/ISRCTN82598401 |
Secondary identifying numbers | 14808 |
- Submission date
- 25/10/2013
- Registration date
- 25/10/2013
- Last edited
- 07/08/2019
- Recruitment status
- Stopped
- Overall study status
- Stopped
- Condition category
- Infections and Infestations
Plain English summary of protocol
Not provided at time of registration
Contact information
Scientific
Centre for Digestive Diseases
Blizard Institute
The Blizard Building
4 Newark Street
London
E1 2AT
United Kingdom
Phone | +44 20 7882 2483 |
---|---|
j.kunkel@qmul.ac.uk |
Study information
Study design | Randomised interventional screening trial |
---|---|
Primary study design | Interventional |
Secondary study design | Randomised controlled trial |
Study setting(s) | GP practice |
Study type | Screening |
Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
Scientific title | Screening for viral hepatitis in migrants in East London: a pilot study of the HEPscreen project comparing screening invitation with and without HIV testing |
Study acronym | HEPscreen |
Study objectives | The aim of this study is to determine any difference in the number of candidates attending for testing in primary health care facilities when offered testing for viral hepatitis with or without concomitant testing for HIV. |
Ethics approval(s) | NRES Committee London - Brent, 08/04/2013, ref: 13/LO/0215 |
Health condition(s) or problem(s) studied | Screening for viral hepatitis |
Intervention | Screening, Addition of invitation for HIV testing to testing for viral hepatitis. The participants will be sent a letter inviting them to come to their GP practice for a questionnaire and a blood test. The difference between the two arms is the text in the invitation letter. The visit to the practice is a one-stop appointment and follow-up is determined by the test results and will take place in the way of usual clinical care. The primary outcome is the number of participants that attend for testing in each arm. Follow Up Length: 12 months Study Entry : Single Randomisation only |
Intervention type | Other |
Primary outcome measure | Number of participants responding to invitation letter; Timepoint(s): 31/03/2013 |
Secondary outcome measures | 1. To determine the prevalence of viral hepatitis in different migrant populations when approached for testing in primary health care facilities. 2. To determine the number of persons infected with hepatitis B or C who then proceed on to secondary, tertiary health care and treatment, respectively. These secondary outcomes will be measured at the end of the study. |
Overall study start date | 15/08/2013 |
Completion date | 31/03/2014 |
Reason abandoned (if study stopped) | Participant recruitment issue |
Eligibility
Participant type(s) | Patient |
---|---|
Age group | Adult |
Lower age limit | 18 Years |
Sex | Both |
Target number of participants | UK Sample Size: 500; Description: 500 people to be invited for testing. The study takes place in the London Borough of Hackney in Primary Care. |
Key inclusion criteria | 1. Migrants (i.e. person or parents born outside the UK in high or intermediate Hepatitis B and C prevalence countries) 2. Male & female, 18 years and older 3. Registered with primary care practices in East London |
Key exclusion criteria | 1. Withheld consent 2. Age < 18 years 3. Previously known infection with HBV, HCV or HIV or previous test 4. Lacking capacity |
Date of first enrolment | 15/08/2013 |
Date of final enrolment | 31/03/2014 |
Locations
Countries of recruitment
- England
- United Kingdom
Study participating centre
E1 2AT
United Kingdom
Sponsor information
University/education
Centre for Digestive Diseases
Blizard Institute
London
E1 2AD
England
United Kingdom
Website | http://www.qmul.ac.uk/ |
---|---|
https://ror.org/026zzn846 |
Funders
Funder type
Government
No information available
Results and Publications
Intention to publish date | |
---|---|
Individual participant data (IPD) Intention to share | No |
IPD sharing plan summary | Not provided at time of registration |
Publication and dissemination plan | Not provided at time of registration |
IPD sharing plan |
Study outputs
Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
---|---|---|---|---|---|
HRA research summary | 28/06/2023 | No | No |
Editorial Notes
07/08/2019: The trial status has been changed to 'Stopped'. According to http://hepscreen.eu/wp-content/uploads/2014/12/HEPscreen_Final-WP6-report_Pilot-studies.pdf, the study was terminated because of poor recruitment.
13/09/2016: No publications found in PubMed, verifying study status with principal investigator.